GS-100 kan AAV9 veektara recombinant NGLY1 gene namaa kan koodeessu dha. Kan US Food and Drug Administration fi European Medicine Agency (EMA) irraa qoricha orphan drug jedhamu argate. Qorichi kun FDA's rare pediatric disease jedhamu bara 2021 fi fast track jedhamu bara darbe argate.
#SCIENCE #West Central Oromo #CU
Read more at Clinical Trials Arena